Aspen Aerogels Q1 net loss narrows to $23.7 million; revenue drops 51.9% to $37.9 million

Aspen Aerogels Inc

Aspen Aerogels Inc

ASPN

0.00
  • Aspen Aerogels posted Q1 2026 revenue of USD 37.9 million, down 51.9%, while net loss narrowed to USD 23.7 million from USD 301.2 million a year earlier.
  • Adjusted EBITDA swung to a loss of USD 12.7 million from a gain of USD 4.9 million, while cash, cash equivalents and restricted cash rose to USD 175.6 million from USD 158.6 million at year-end 2025.
  • Thermal barrier segment revenue fell to USD 16.3 million from USD 48.9 million due to reduced customer demand following changes in regulatory frameworks and incentive programs.
  • East Providence, Rhode Island manufacturing facility expects staged restart beginning in May following an April 8 explosion; existing inventory and an external manufacturing facility have supported customer demand.
  • Forecasts Q2 revenue of USD 40 million to USD 48 million, with net loss of USD 14 million to USD 20 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Aerogels Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605070630PRIMZONEFULLFEED9715169) on May 07, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.